|
Published by: Mintel International Group Ltd.
Published: Aug. 1, 2008 - 81 Pages
Table of Contents
- Scope and Themes
- What you need to know
- Definition
- Data sources
- Sales data
- Consumer survey data
- Abbreviations and terms
- Abbreviations
- Terms
- Executive Summary
- Diabetes: a complex, costly condition
- Diabetes monitoring market grows with prevalence
- Competitive context
- Monitors outsell lancets/devices based on price points
- Market driven by prevalence, obesity/overweight, aging population, and increasing ethnic population
- Innovations focus on insulin delivery, monitoring
- Marketing comprises traditional TV/print, promotions, awareness
- Consumer attitudes and beliefs
- Understanding Diabetes
Key points
- Overview
- Incidence and prevalence of diabetes
- Figure 1: CDC estimates of the diagnosed diabetic population, 1980-2005
- Pre-diabetes
- Age, race, and gender factors
- Figure 2: The U.S. diabetic population, by age, gender and race/ethnicity, 2005 and 2007
- Pediatric cases increasing
- Diagnosis
- Risk factors
- Treatment and care
- Type 1 diabetes treatment
- Type 2 diabetes treatment
- Daily and long term care for Type 1 and Type 2 sufferers alike
- Cost of diabetes
- Diabetes Testing
- Key points
- Reasons for testing blood glucose
- Sales of glucose testing kits and lancets/devices
- Diabetes product suppliers alter retail landscape
- Figure 3: Sales and forecast of diabetes testing products at FDMx outlets, at current prices, 2003-13
- Figure 4: Sales and forecast of diabetes testing products at FDMx outlets, at inflation adjusted prices, 2003-13
- Wal-Mart sales
- Competitive Context
- Glucose monitoring
- Traditional home blood glucose monitoring
- Alternative site meters
- Minimally invasive/non-invasive monitors
- Retailers make room for direct suppliers
- Figure 5: Access Diabetic Supply television ad, 2007
- Figure 6: AmMed Direct television ad, 2008
- Segment Performance
- Key points
- Sales of glucose testing kits and lancets/devices
- Figure 7: Sales of diabetes testing products at FDMx outlets, 2006/07 and 2007/08
- Segment Performance—Glucose Testing Devices
- Key points
- Glucose monitors drop through FDMx but are estimated to grow overall
- Figure 8: U.S. sales and forecast of glucose testing devices at FDMx outlets, at current prices, 2003-13
- Segment Performance—Lancet/Devices
- Key points
- Despite decline at FDM, lancets/devices sales forecast to increase with diabetes prevalence
- Figure 9: U.S. sales and forecast of lancet/devices at FDMx outlets, at current prices, 2003-13
- Market Drivers
- Key points
- Prevalence and incidence of diabetes continues to grow
- Growing number of overweight and obese
- Overweight, obese children at increased risk
- Figure 10: Child population, by age, 2003-13
- Sedentary lifestyle
- Aging population spurs diabetes incidence, complicates management
- Figure 11: Adult population, by age, 2003-13
- Figure 12: Percent of adults with diabetes using diabetes medication, by age, U. S. 1997-2006
- Ethnic minorities more predisposed to diabetes and causes
- Figure 13: Population, by race and Hispanic origin, 2003-13
- Figure 14: Age-standardized percent of U.S. adults with diabetes using diabetic medications, by race/Hispanic origin, 1997-2006
- Innovation and Innovators
- Treatment innovations
- Insulin delivery
- Monitoring innovations
- Relief from blood requirements
- Marketing to Diabetics
- Overview
- The role of media among diabetics
- Figure 15: Product selection among diabetics and those who consider themselves at risk for diabetes, January-November 2007
- Figure 16: Media sources for information and entertainment among diabetics and those who consider themselves at risk for diabetes, January-November 2007
- Figure 17: Attitudes towards diabetes advertisements/information, by gender and age, June 2008
- TV ads
- Bayer
- Figure 18: Bayer television ad, 2008
- Figure 19: Bayer Breeze2 television ad, 2008
- Figure 20: Bayer Contour television ad, 2008
- Amylin Pharmaceuticals, Inc./Eli Lilly
- Figure 21: Byetta television ad, 2007
- Abbot Labs, Inc.
- Figure 22: FreeStyle television ad, 2008
- LifeScan
- Figure 23: OneTouch Ultra television ad—hectic schedule, 2008
- Figure 24: OneTouch Ultra television ad—family, 2008
- Pfizer
- Figure 25: Pfizer television ad, 2007
- Merck
- Figure 26: Januvia television ad, 2008
- USA Medical, LLC
- Figure 27: USA Medical television ad, 2008
- Diabetes Diagnosis
- Key Points
- Diabetes diagnosis and testing
- Figure 28: Diabetes diagnosis and testing, by gender, June 2008
- Figure 29: Diabetes diagnosis and testing, by age, June 2008
- Figure 30: Diabetes diagnosis and testing, by race/Hispanic origin, June 2008
- Condition severity
- Figure 31: Severity of diabetes, by gender and age, January-November 2007
- Figure 32: Severity of diabetes, by race/Hispanic origin, January-November 2007
- Body/health feelings pre-diagnosis and reasons for seeing a physician
- Coping with Diabetes Diagnosis
- Key Points
- Post diagnosis feelings
- Attitudes toward support receiving
- Figure 33: Level of support for diabetes from doctors, family and friends, by age, June 2008
- Interest in support groups
- Figure 34: Interest or participation in various diabetes support groups, by age, June 2008
- Managing Diabetes
- Time spent thinking and managing varies
- Meals and Eating
- Key points
- Controlling diet
- Figure 35: Watching diet, by gender and age, January-November 2007
- Figure 36: Watching diet, by race/Hispanic origin, January-November 2007
- Figure 37: Reasons for watching diet, by gender and age, January-November 2007
- Figure 38: Reasons for watching diet, by race/Hispanic origin, January-November 2007
- Ideal foods for diabetic diet management
- Types of foods bought when controlling diet for diabetic reasons
- Figure 39: Types of foods bought when watching diet for diabetic reasons, by gender and age, January-November 2007
- Figure 40: Types of foods bought when watching diet for diabetic reasons, by race/Hispanic origin, January-November 2007
- Meal plans and non-prescription product usage
- Figure 41: Types of non-prescription products bought when watching diet for diabetic reasons, by gender and age, January-November 2007
- Figure 42: Types of non-prescription products bought when watching diet for diabetic reasons, by race/Hispanic origin, January-November 2007
- Changing eating habits
- Figure 43: Diabetes management and diet, by age, June 2008
- Challenges to meal planning and eating
- The carb connection
- Exercising
- Exercise routines
- Benefits from working out
- Blood Sugar
- Testing
- Need for blood, cost high on concern meter
- Insurance and high cost of medicine pose challenge
- Medication
- Key points
- Following medication regimens
- Figure 44: Diabetes management and medications, by age, June 2008
- Rx vs. OTC
- Figure 45: Rx vs. OTC diabetes medication used, by gender and age, January-November 2007
- Attitudes towards needles and injections, insulin
- Treatment plans
- Attitudes of People with Pre-diabetes
- Attitudes towards avoiding diabetes
- Figure 46: Attitudes towards preventing diabetes among pre-diabetics, June 2008
- Attitudes, concerns towards diabetes and family history of diabetes
- Figure 47: Attitudes towards and history of diabetes, by gender and age, June 2008
- Avoiding Diabetes
- Steps taken to prevent diabetes
- Figure 48: Steps taken to prevent diabetes, by gender and age, June 2008
- Figure 49: Steps taken to prevent diabetes, by race/Hispanic origin, June 2008
- Appendix: Other Useful Consumer Tables
- Diabetes diagnosis and testing
- Figure 59: Diabetes diagnosis and testing, by household income, June 2008
- Rx vs. OTC
- Figure 60: Rx vs. OTC diabetes medication, by household income, January-November 2007
- Steps taken to prevent diabetes
- Figure 61: Steps taken to prevent diabetes, by household income, June 2008
- Controlling diet
- Figure 62: Watching diet, by household income, January-November 2007
- Figure 63: Reasons for watching diet, by household income, January-November 2007
- Types of foods bought when controlling diet for diabetic reasons
- Figure 64: Types of non-prescription products bought when watching diet for diabetic reasons, by race/Hispanic origin, January-November 2007
- Figure 65: Types of foods bought when watching diet for diabetic reasons, by household income, January-November 2007
- Changing eating habits
- Figure 66: Diabetes management and diet, by household income, June 2008
- Appendix: Trade Associations
AbstractDiabetes is a highly complex disease that entails a range of screening methods, treatment, monitoring, and management. Comprised of pre-diabetes, Type 1 (an autoimmune disease) and Type 2 (a metabolic disorder), diabetes affects 23.6 million people in the U.S., with another 57 million considered pre-diabetic, which typically evolves into Type 2. This report analyzes the prevalence, incidence, monitoring and treatment involved in managing diabetes, and also provides analysis of:
- The risk factors for contraction, including overweight/obesity, age, ethnicity, family history of diabetes, high blood pressure and high cholesterol, as well as other factors
- The overall national costs of managing the condition
- The growth of the monitoring market through FDMx channels and direct suppliers
- Competition between glucose monitor manufacturers, which strive to make monitoring glucose levels more convenient and painless through a range of technical innovations
- Drivers for the diabetic market, including population growth among key demographics such as older Americans and ethnic groups
- Innovations in glucose delivery
- The nature of marketing to diabetics
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|